EQT Life Sciences Team
Photo of Fouad Azzam, Partner at EQT Life Sciences
Fouad Azzam
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Boston (MA)
Photo of Daniela Begolo, Managing Director at EQT Life Sciences
Daniela Begolo
EQT Life Sciences·Managing Director
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Philipp Bräuer, Associate at EQT Life Sciences
Philipp Bräuer
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Munich (Germany)
Photo of Christoph Broja, Managing Director at EQT Life Sciences
Christoph Broja
EQT Life Sciences·Managing Director
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Germany
Photo of Drew Burdon, Partner at EQT Life Sciences
Drew Burdon
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in United Kingdom
Photo of Rudy Dekeyser, Partner at EQT Life Sciences
Rudy Dekeyser
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Belgium
Investors in BioTech (Series B)
Photo of John de Koning, Partner at EQT Life Sciences
John de Koning
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Arno de Wilde, Investor at EQT Life Sciences
Arno de Wilde
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Laurenz Govaerts, Vice President at EQT Life Sciences
Laurenz Govaerts
EQT Life Sciences·Vice President
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Brussels
Photo of Sonia Hallen, Vice President at EQT Life Sciences
Sonia Hallen
EQT Life Sciences·Vice President
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Pre-seed), Investors in BioTech (Seed)
Photo of Kevin Hammon, Associate at EQT Life Sciences
Kevin Hammon
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Bruno Holthof, Partner at EQT Life Sciences
Bruno Holthof
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Oxford (United Kingdom)
Photo of Cillian King, Managing Director at EQT Life Sciences
Cillian King
EQT Life Sciences·Managing Director
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series B), Investors in Diverse Investors (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
Photo of Martijn Kleijwegt, Partner at EQT Life Sciences
Martijn Kleijwegt
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series A)
Photo of René Kuijten, Partner at EQT Life Sciences
René Kuijten
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Juliette Lee, Associate at EQT Life Sciences
Juliette Lee
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in United Kingdom
Photo of Maximilian Moser, Associate at EQT Life Sciences
Maximilian Moser
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Geraldine O'Keeffe, Partner at EQT Life Sciences
Geraldine O'Keeffe
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Anne Portwich, Partner at EQT Life Sciences
Anne Portwich
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Joachim Rothe, Partner at EQT Life Sciences
Joachim Rothe
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Munich (Germany)
Photo of Philip Scheltens, Partner at EQT Life Sciences
Philip Scheltens
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series B)
Photo of Ishaan Tewarie, Associate at EQT Life Sciences
Ishaan Tewarie
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health IT (Pre-seed), Investors in AI (Pre-seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed)
Photo of Clemens van Blitterswijk, Venture Partner at EQT Life Sciences
Clemens van Blitterswijk
EQT Life Sciences·Venture Partner
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Felice Verduyn - van Weegen, Partner at EQT Life Sciences
Felice Verduyn - van Weegen
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Photo of Mark Wegter, Partner at EQT Life Sciences
Mark Wegter
Sweet spot: $25.0M
Range: $11.0M - $65.0M
Investors in Amsterdam (Netherlands)
Investors in BioTech (Pre-seed), Investors in BioTech (Seed)